Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentric,Double-blind,Placebo Controlled,Phase-2 Study to Assess the Safety and Efficacy of Homeopathic Medicine Rhus Toxicodendron 30 in the Treatment of Rheumatoid Arthritis .

NCT01905735 is registered in ClinicalTrials.gov with Healthcare Homoeo Charitable Society as lead sponsor.

NCT NCT01905735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01905735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentric,Double-blind,Placebo Controlled,Phase-2 Study to Assess the Safety and Efficacy of Homeopathic Medicine Rhus Toxicodendron 30 in the Treatment of Rheumatoid Arthritis .
Lead sponsor
Healthcare Homoeo Charitable Society
Phase
Phase 2
Overall status
Unknown status
Start date
August 31, 2013
Completion date
February 28, 2014
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis.